Discussing Regulatory Affairs: Leadership Perspectives & 2024 Survey Insights

Join the discussion to hear from industry leaders sharing key insights and learnings from the recent survey conducted across the life sciences industry from Celegence in partnership with RAPS which had nearly 700 participants. This is a thought-provoking session exploring the findings and insights on topics such as top challenges and opportunities, planned investments near and long term, and alignment to changing technology such as real AI/Artificial Intelligence use cases. The speakers will look at specifics in pharma such as efficiency in publications and submission including eCTD v4.0 (electronic common technical document), lean authoring, readiness for IDMP (identification of medicinal products), and evolving practices in medical writing. On medical devices, the session will cover specifics such as MDR/IVDR remediation and maintenance, QMS, and technical file management.

Don’t miss this opportunity to enhance your regulatory skills and understanding.

Request the detailed survey reports for both Medical Devices and Pharmaceuticals

Webinar Speakers

Sonia Veluchamy

CEO, Co-founder, Celegence

Punya Abbhi

COO, Co-founder, Celegence

Gain actionable knowledge and insights with our webinar focusing on these key areas:

  • Get a pulse on the latest trends in regulatory affairs for pharma and medical devices

  • Compare top challenges, pain points and shifts in skills, process and technology

  • Explore specifics on medical writing, IDMP, eCTD v4.0, document/file management systems, MDR/IVDR remediation and maintenance

  • See future investment areas related to regulatory and compliance

  • Discover real AI use cases in regulatory affairs and operations working in assistance to humans

Are you seeking assistance with a regulatory compliance need?

Please complete the form below to outline your medical device/pharmaceutical/IVD regulatory support requirements. Our team will promptly review your submission and reach out to confirm a consultation time. Thank you for your interest.

  • Hidden
  • Hidden
  • Hidden
  • Hidden
  • This field is for validation purposes and should be left unchanged.